Jan. 16, 2020 —
We plan to begin the subject audit in January 2020. The objective of this audit is to determine whether the Defense Health Agency properly accounted for and safeguarded pharmaceuticals at selected DoD military treatment facilities in accordance with Defense Health Agency and Military Department guidance. We will consider suggestions from management on additional or revised objectives.